Healthcare Opportunity

Osteoarthritis is a chronic disease that develops over many years.

90% of people with osteoarthritis have limited mobility and 30% is even unable to perform normal activities of daily living. In fact this condition is considered the fourth leading cause of disability among women and eighth among men.

The joints are skeletal components that allow movement and, therefore, be functionally independent and relate to others. They are formed by the union of two bones through the joint capsule. Inside of them there is generally a fluid called synovial fluid that is produced by the synovium. The bone ends that join to form the joint are covered with articular cartilage.

Osteoarthritis is a disease that damages the articular cartilage and causes pain, stiffness and functional disability.

Since not long ago we have a new therapeutic approach based on the use of plasma rich in growth factors (PRGF) that could stop or at least delay its progression.

Your application can revolutionize treatments currently available.

PRGF and optimizes mimics physiological repair mechanisms are in place spontaneously in all tissues, including articular cartilage of the knee and hip after an injury.

It was noted that five days after application of the PRGF is, depending on the tissue, up to 40 times more cells in the treated area to work (rebuilding, healing, regenerating, and ultimately, healing it).

The sex and age of the patients did not influence the response to this therapy but involved the degree of osteoarthritis. The most important clinical improvement occurs in patients whose arthritic process is less advanced at the time of the treatment.

The PRGF replaces the pathological synovial fluid spill situations, inflammation and joint pain. Also acts on cells of the synovium and synoviocytes (responsible for the production of synovial fluid that bathes the joint completely) by stimulating the production of hyaluronic acid and other bioactive molecules. The result is improved quality of synovial fluid acts as anti-inflammatory and reduces pain.

The clinical efficacy of PRGF in the joint can be attributed to several important effects:

· Effect anabolic metabolism (formation) of cartilage.

· Lock the degradation of cartilage.

· Returning a physiological environment in inhibiting joint inflammation and reducing pain.

It causes problems of rejection or allergy, or adverse side effects are and can be applied safely as often as necessary.